Pure Global

Visual Stimulation for Pain Relief - Trial NCT06276881

Access comprehensive clinical trial information for NCT06276881 through Pure Global AI's free database. This phase not specified trial is sponsored by Dandelion Science and is currently Completed. The study focuses on Pain. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06276881
Completed
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06276881
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Visual Stimulation for Pain Relief
Pain Relief Through Artificial Intelligence (AI) -Guided Visual Stimulation

Study Focus

Pain

Visual Stimulation

Interventional

behavioral

Sponsor & Location

Dandelion Science

Hoboken, United States of America

Timeline & Enrollment

N/A

Jun 03, 2022

May 01, 2023

75 participants

Primary Outcome

Visual Analog Scale (VAS) Score,Contact Heat Evoked Potential (CHEP)

Summary

The goal of this study is to investigate a novel neuromodulatory approach utilizing visual
 stimulation to impact pain perception in healthy participants.

ICD-10 Classifications

Pain, unspecified
Pain, not elsewhere classified
Pain in limb
Acute pain
Other chronic pain

Data Source

ClinicalTrials.gov

NCT06276881

Non-Device Trial